Maturix has joined Saint-Gobain to strengthen digital construction chemicals platform
Maturix, a leading provider of real-time monitoring solutions for the concrete industry, has been acquired by Saint-Gobain as part of the group’s strategic expansion of its digital construction chemicals platform.
Based in Denmark, Maturix offers cutting-edge wireless sensor technology that allows remote, real-time monitoring of concrete properties during the curing and hardening process. This innovation helps contractors optimize operations and meet traceability requirements more efficiently. By reducing the concrete construction cycle by up to 50%, Maturix boosts job-site productivity while simultaneously improving concrete quality and ensuring a high level of structural performance.
Saint-Gobain is a publicly traded global group operating in 80 countries with over 161,000 employees. A leader in light and sustainable construction, the group designs, manufactures and distributes high-performance materials and solutions for the construction and industrial sectors.
Oaklins’ team in Denmark acted as the strategic and financial advisor to the owners of Maturix in this transaction.
Lars Friis
Chairman and shareholder, Maturix
Talk to the deal team
Related deals
Niscon Inc. has been acquired by SGPS ShowRig
Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.
Learn moreOSL has been acquired by Terma
OSL Group Limited, a leader in counter-drone security and safety systems, has been acquired by Terma AS, a Denmark-based global provider of mission-critical solutions for defense, aerospace and security.
Learn moreBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Learn more